San Jose, CA, United States of America

Mihir Naware

This inventor holds 9 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Pacesetter, Inc.. Active years: 2010-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mihir Naware. Retrieved from https://idiyas.com/inventor/mihir-naware-6rbsvwej

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 66.7


Average Co-Inventor Count = 4.3

ph-index = 7

Forward Citations = 263(Granted Patents)


Location History:

  • San Jose, CA (US) (2010 - 2015)
  • Evanston, IL (US) (2015)

Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Mihir Naware in Cardiac Technology

Introduction

Mihir Naware, an esteemed inventor based in San Jose, California, has made significant strides in the field of medical technology with a focus on cardiac health. With a total of nine patents to his name, Naware has contributed innovative solutions that enhance the functionality of implantable medical devices, particularly those used in monitoring and adjusting cardiac performance.

Latest Patents

Two of Naware's latest patents showcase his pioneering work. The first patent, titled "System and method for estimating electrical conduction delays from immittance values measured using an implantable medical device," outlines techniques for estimating electrical conduction delays within a patient's heart by utilizing measured immittance values. This method involves gathering impedance or admittance data from the heart through devices such as pacemakers and converting these values into conduction delay metrics using predetermined conversion factors. This information can subsequently provide insights into cardiac pressure values and assist in adapting pacing parameters based on estimated left atrial pressure (LAP).

The second patent, "System and method for estimating cardiac pressure based on cardiac electrical conduction delays using an implantable medical device," further extends these techniques. This patent emphasizes estimating left atrial pressure based on interventricular conduction delays, utilizing a set of calibration-derived conversion factors. This innovation also allows for periodic re-calibration of these values directly by the implantable device, enhancing its accuracy and responsiveness in monitoring heart failure conditions.

Career Highlights

Naware's career at Pacesetter, Inc. has been marked by his commitment to advancing cardiac health technologies. His extensive research and innovative developments have not only secured patents but have also established him as a reference point in the medical device industry focusing on heart performance. His work aims to improve patient outcomes by leveraging technology to create more effective monitoring solutions.

Collaborations

In his professional journey, Mihir Naware has collaborated with notable coworkers, including Dorin Panescu and Brian Jeffrey Wenzel. Together, they have contributed to the research and development efforts at Pacesetter, Inc., driving innovations that reflect the team's collective expertise and commitment to advancing cardiac medical technology.

Conclusion

Mihir Naware's contributions through his patents are paving the way for novel solutions in cardiac monitoring. His innovative methodologies and collaboration efforts highlight the vital intersection of technology and healthcare, reinforcing the importance of continuous innovation in medical devices to improve patient care and outcomes. As the landscape of cardiac health technology evolves, Naware's work will undoubtedly play a crucial role in shaping future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…